- Home
- SWIN vs PULM Comparison
SWIN vs PULM Comparison
Compare SWIN & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- PULM
- Stock Information
- Founded
- SWIN 2017
- PULM 2003
- Country
- SWIN Hong Kong
- PULM United States
- Employees
- SWIN N/A
- PULM N/A
- Industry
- SWIN
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- PULM Health Care
- Exchange
- SWIN Nasdaq
- PULM Nasdaq
- Market Cap
- SWIN 27.9M
- PULM 30.9M
- IPO Year
- SWIN 2023
- PULM N/A
- Fundamental
- Price
- SWIN $1.71
- PULM $6.06
- Analyst Decision
- SWIN
- PULM
- Analyst Count
- SWIN 0
- PULM 0
- Target Price
- SWIN N/A
- PULM N/A
- AVG Volume (30 Days)
- SWIN 129.0K
- PULM 22.0K
- Earning Date
- SWIN 04-15-2025
- PULM 05-09-2025
- Dividend Yield
- SWIN N/A
- PULM N/A
- EPS Growth
- SWIN N/A
- PULM N/A
- EPS
- SWIN N/A
- PULM N/A
- Revenue
- SWIN $2,419,000.00
- PULM $7,806,000.00
- Revenue This Year
- SWIN N/A
- PULM N/A
- Revenue Next Year
- SWIN $61.68
- PULM $134.88
- P/E Ratio
- SWIN N/A
- PULM N/A
- Revenue Growth
- SWIN N/A
- PULM 6.96
- 52 Week Low
- SWIN $1.16
- PULM $1.72
- 52 Week High
- SWIN $43.60
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- SWIN 54.26
- PULM 36.59
- Support Level
- SWIN $1.50
- PULM $7.16
- Resistance Level
- SWIN $1.80
- PULM $7.33
- Average True Range (ATR)
- SWIN 0.23
- PULM 0.52
- MACD
- SWIN -0.01
- PULM -0.17
- Stochastic Oscillator
- SWIN 45.55
- PULM 4.00
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.